SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunityBio converts from Immunomedics
IBRX 2.110-1.4%Nov 6 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jargonweary who wrote (995)5/5/2025 1:49:05 PM
From: galt1 Recommendation

Recommended By
bobbseytwins2001

   of 1229
 
Sounds eerlily familiar, as in IMMU, except that IBRX already has one approved indication. No doubt the owner and Sr. mgmt leave much to be desired. Institutional ownership, until recently, has had very little holdings in IBRX, probably because Patrick holds soo much and shares soo little. I do think that the recent stakeholders will "shake the tree" pretty hard, going forward. I'm expecting more news on those fronts and other fronts, soon. Downside seems much less than upside, going forward, IMO, which is the reason I'm adding more. That, and my basis continues to fall, just like a knife, come to think of it. Ha Ha.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News